New research in the June 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network found that when alectinib—a safe and effective small molecule kinase inhibitor used to...
Catching cancer earlier and achieving more accurate initial diagnostics are two of the key benefits of breakthrough artificial intelligence technology that a European company...
BPGbio, Inc., a leading AI-powered biopharma that focuses on oncology, neurology and rare diseases, announced that it will continue clinical validation of a novel...
Frost & Sullivan recently assessed the healthcare industry and, based on its findings, recognizes Gleneagles Hospital Kuala Lumpur with the 2023 Malaysia Hospital Customer Value Leadership Award....
Dante Genomics, a global leader in genomics and precision medicine, announced a free, initial feature of its platform agnostic proprietary B2B software to automatically...
